Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Correvio Pharma Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Correvio Pharma Corp, Medical Devices Deals, 2012 to YTD 2018 10
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Evotec and Artesian Therapeutics Enter into Agreement 13
Cardiome Pharma Enters into Agreement with Chong Kun Dang for BRINAVESS 14
Cardiome Pharma Enters into Agreement with Mitsubishi Tanabe Pharma Europe 15
Cardiome Pharma Enters into Commercialization Agreement with AOP Orphan Pharma 16
Cardiome Pharma Enters into Agreement with Eddingpharm to Develop and Commercialize Brinavess 17
Cardiome Pharma Enters into Co-Marketing Agreement with Aspen Pharma for Brinavess 18
Correvio International Enters into Distribution Agreement with Eurolab Especialidades for Brinavess 19
Cardiome Pharma Enters into Commercialization Agreement with AOP Orphan Pharma for Aggrastat 20
Cardiome Pharma Enters Into Commercialization Agreement With UDG Healthcare For Brinavess In Ireland 21
Cardiome Enters Into Commercialization Agreement With Algorithm For Brinavess 22
Cardiome Pharma Enters Into Commercialization Agreement With Tzamal Medical For Brinavess 23
Cardiome Pharma Enters Into Commercialization Agreement With AOP Orphan Pharma For Brinavess 24
Cardiome Pharma Enters Into Co-Marketing Agreement With Merck For Brinavess 25
Licensing Agreements 26
ZAO Firma Enters into Licensing Agreement with Correvio 26
Correvio International Enters into Licensing Agreement with ATCO Laboratories 27
Cardiome Pharma Enters into Licensing Agreement with Basilea Pharma 28
Tzamal Medical Enters into Licensing Agreement with Cardiome Pharma 29
Cardiome Enters into Licensing Agreement with Allergan for XYDALBA 30
Eddingpharm Enters into Licensing Agreement with Correvio International 31
SteadyMed Enters into Licensing Agreement with Cardiome Pharma 32
Equity Offering 33
Correvio Pharma to Raise up to USD30 Million in Public Offering of Shares 33
Correvio Pharma Plans to Raise up to USD250 Million in Public Offering of Securities 34
Cardiome Pharma Raises USD34.5 Million in Public Offering of Shares 35
Cardiome Pharma to Raise up to USD20 Million in Private Placement of Shares 37
Cardiome Pharma Raises USD23 Million in Public Offering of Shares 39
Cardiome Pharma Completes Public Offering Of Shares For Us$13.7 Million 41
Acquisition 43
Cipher Pharma Acquires Cardiome Pharma for USD19.5 Million 43
Cardiome Pharma Acquires Correvio, Cardiovascular Products Provider 45
CarCor Investment Acquires 16.6% Stake In Cardiome Pharma 46
Correvio Pharma Corp – Key Competitors 47
Correvio Pharma Corp – Key Employees 48
Correvio Pharma Corp – Locations And Subsidiaries 49
Head Office 49
Other Locations & Subsidiaries 49
Recent Developments 50
Financial Announcements 50
Aug 14, 2018: Correvio announces second quarter 2018 financial results 50
May 15, 2018: Correvio Announces First Quarter 2018 Financial Results 52
Mar 13, 2018: Cardiome Reports Fourth Quarter and Full Year 2017 Financial Results 54
Nov 14, 2017: Cardiome Reports Third Quarter 2017 Financial Results 56
Aug 08, 2017: Cardiome Reports Second Quarter 2017 Financial Results 58
May 15, 2017: Cardiome Reports First Quarter 2017 Financial Results 60
Mar 07, 2017: Cardiome Reports Fourth Quarter and Full Year 2016 Financial Results 61
Corporate Communications 63
May 16, 2017: Cardiome Reports Changes To Senior Management Team 63
Other Significant Developments 64
May 17, 2018: Correvio Pharma Formerly Cardiome Pharma, Announces Stock Ticker Symbol Change to CORV 64
May 10, 2018: Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call 65
Appendix 66
Methodology 66
About GlobalData 66
Contact Us 66
Disclaimer 66
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Correvio Pharma Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Correvio Pharma Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Correvio Pharma Corp, Medical Devices Deals, 2012 to YTD 2018 10
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Evotec and Artesian Therapeutics Enter into Agreement 13
Cardiome Pharma Enters into Agreement with Chong Kun Dang for BRINAVESS 14
Cardiome Pharma Enters into Agreement with Mitsubishi Tanabe Pharma Europe 15
Cardiome Pharma Enters into Commercialization Agreement with AOP Orphan Pharma 16
Cardiome Pharma Enters into Agreement with Eddingpharm to Develop and Commercialize Brinavess 17
Cardiome Pharma Enters into Co-Marketing Agreement with Aspen Pharma for Brinavess 18
Correvio International Enters into Distribution Agreement with Eurolab Especialidades for Brinavess 19
Cardiome Pharma Enters into Commercialization Agreement with AOP Orphan Pharma for Aggrastat 20
Cardiome Pharma Enters Into Commercialization Agreement With UDG Healthcare For Brinavess In Ireland 21
Cardiome Enters Into Commercialization Agreement With Algorithm For Brinavess 22
Cardiome Pharma Enters Into Commercialization Agreement With Tzamal Medical For Brinavess 23
Cardiome Pharma Enters Into Commercialization Agreement With AOP Orphan Pharma For Brinavess 24
Cardiome Pharma Enters Into Co-Marketing Agreement With Merck For Brinavess 25
ZAO Firma Enters into Licensing Agreement with Correvio 26
Correvio International Enters into Licensing Agreement with ATCO Laboratories 27
Cardiome Pharma Enters into Licensing Agreement with Basilea Pharma 28
Tzamal Medical Enters into Licensing Agreement with Cardiome Pharma 29
Cardiome Enters into Licensing Agreement with Allergan for XYDALBA 30
Eddingpharm Enters into Licensing Agreement with Correvio International 31
SteadyMed Enters into Licensing Agreement with Cardiome Pharma 32
Correvio Pharma to Raise up to USD30 Million in Public Offering of Shares 33
Correvio Pharma Plans to Raise up to USD250 Million in Public Offering of Securities 34
Cardiome Pharma Raises USD34.5 Million in Public Offering of Shares 35
Cardiome Pharma to Raise up to USD20 Million in Private Placement of Shares 37
Cardiome Pharma Raises USD23 Million in Public Offering of Shares 39
Cardiome Pharma Completes Public Offering Of Shares For Us$13.7 Million 41
Cipher Pharma Acquires Cardiome Pharma for USD19.5 Million 43
Cardiome Pharma Acquires Correvio, Cardiovascular Products Provider 45
CarCor Investment Acquires 16.6% Stake In Cardiome Pharma 46
Correvio Pharma Corp, Key Competitors 47
Correvio Pharma Corp, Key Employees 48
Correvio Pharma Corp, Subsidiaries 49
List of Figures
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Correvio Pharma Corp, Medical Devices Deals, 2012 to YTD 2018 10